Interested in learning more about NDEWS? Join us for our annual summit! The NDEWS 5th Annual Summit will be held on Saturday, June 13 from 2:00–6:00 pm PT as a hybrid event. While registration for the CPDD conference is not required to attend the NDEWS Summit, we encourage you to register and join us for additional presentations by NDEWS Coordinating Center and Early Warning Network.
We invite you to join us for the upcoming Our Community, Our Health Town Hall - NDEWS Webinar ft. DEA Lab Director Dr. Agnes Winokur presenting on "orphines” (benzimidazol-2-ones). These synthetic opioids recently emerged as adulterants in the US unregulated drug supply.
We invite you to join us for the upcoming Our Community, Our Health Town Hall - NDEWS Webinar with the National Association of State Controlled Substances Authorities (NASCSA). Topic: The National Drug Early Warning System: Emergency Overdose Trends, Emerging Drugs of Abuse and Why this Matters to States
During the latest Our Community, Our Health Town Hall - NDEWS Webinar, on Thursday, November 20, 2025, the Kindbridge Research Institute team provided an in-depth look at Florida's Playwise program, a statewide initiative providing gambling helpline services, responsible gambling education, and tailored community outreach.
Article published in TIME, features insight from NDEWS Co-Director Joseph Palamar and SAG member Alex Krotulski, exploring the rise of nitazenes. The article describes nitazenes, discusses emerging trends, and explains the challenges with detection of the substance.
NDEWS Deputy Director, Dr. Joseph Palamar, presented along with Dr. Joshua DeBord of the Center for Forensic Science Research and Education (CFSRE) on monitoring of drug trends in the US, during the Trends, Analysis, & Threats webinar, hosted by the Overdose Response Strategy (ORS) Program.
NIDA T32 Predoctoral trainee Vijaya L. Seegulam graduated Friday, August 8, with her PhD in Epidemiology from the University of Florida. Additionally, in July, NDEWS MPI Dr. Joseph Palamar was promoted to Professor of Population Health at NYU Langone Health. Congratulations to Drs. Seegulam and Palamar.
7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat report by the FDA highlights the work of NDEWS' Web Monitoring team.
Following the NDEWS 4th Annual Summit, members of the NDEWS Coordinating Center (CC) will present a late-breaking abstract, an oral presentation, symposiums, and posters showcasing our latest data while at CPDD. In addition to presenting at CPDD, NDEWS Director, Dr. Linda Cottler (MPI), will deliver the keynote during the 2025 CPDD/RSA Joint Program focusing on NDEWS.
Teen nonmedical misuse of medications may be more common than we believed. In Psychology Today’s Addiction Outlook column, Dr. Mark Gold discusses that teen nonmedical misuse of medications like dextromethorphan (DXM) and promethazine may be more widespread than previously recognized. Dr. Linda B. Cottler, Director of NDEWS, warns, “Parents…
